东吴证券研报指出，新宙邦业绩符合市场预期。公司预估25年实现营收96.4亿元，同比+22.8%，预估实 现归母净利11.0亿元，同比+16.6%。电解液六氟涨价贡献业绩弹性、单位盈利明显修复。26年公司半导 体冷却液产品客户认证有望基本完成，预计26年开始放量，且我们预计26年海德福减亏，预计氟化工合 计贡献10亿利润，增速恢复。考虑公司六氟及VC涨价幅度显著，25Q4单位盈利明显修复，26年预计将 进一步体现涨价弹性，以及氟化工业务新产品贡献增量，给予26年25xPE，目标价79.8元，维持"买 入"评级。 ...

Core Viewpoint - Dongwu Securities report indicates that Xinzhou Bang's performance meets market expectations, with projected revenue of 9.64 billion yuan in 2025, representing a year-on-year increase of 22.8%, and a projected net profit attributable to shareholders of 1.1 billion yuan, reflecting a year-on-year growth of 16.6% [1] Group 1 - The price increase of electrolyte hexafluorides contributes to performance elasticity, and unit profitability shows significant recovery [1] - In 2026, customer certification for semiconductor cooling liquid products is expected to be largely completed, with anticipated volume growth starting in 2026 [1] - The company is expected to reduce losses from Haidefu in 2026, with fluorochemical products projected to contribute 1 billion yuan in profit, indicating a recovery in growth rate [1] Group 2 - Considering the significant price increases of hexafluoride and VC, unit profitability is expected to show notable recovery in Q4 2025, with further price elasticity anticipated in 2026 [1] - New product contributions from the fluorochemical business are expected to provide incremental growth [1] - A target price of 79.8 yuan is set for 2026, with a maintained "buy" rating based on a 25x PE ratio [1]

Core Viewpoint - The company is expected to achieve revenue of 9.64 billion yuan in 2025, representing a year-on-year increase of 22.8%, with a projected net profit attributable to shareholders of 1.1 billion yuan, up 16.6% year-on-year, and a non-recurring net profit of 1.09 billion yuan, up 14.5% year-on-year [1] Group 1: Financial Performance - The company forecasts a net profit of 350 million yuan for Q4 2025, with a quarter-on-quarter increase of 45.5% and a year-on-year increase of 32.5% [1] - The estimated non-recurring net profit for Q4 2025 is 370 million yuan, with a quarter-on-quarter increase of 53% and a year-on-year increase of 50% [1] - The company expects to ship over 80,000 tons of electrolyte in Q4 2025, a 35% year-on-year increase, and over 280,000 tons for the entire year, a 45% increase [1] Group 2: Profitability and Market Dynamics - The electrolyte segment is projected to contribute approximately 100 million yuan in profit for Q4, with a unit profit recovery to 1,200 yuan per ton, primarily driven by price increases in hexafluorophosphate and VC [1] - The company anticipates that the fluorochemical segment will generate around 200 million yuan in profit for Q4 2025, with a slight increase quarter-on-quarter [2] - The semiconductor cooling liquid product is expected to complete customer certification in 2026, leading to volume growth, while the fluorochemical segment is projected to contribute 1 billion yuan in profit, indicating a recovery in growth [2] Group 3: Investment Outlook - The company maintains a "buy" rating, with a target price of 79.8 yuan, based on significant price increases for hexafluorophosphate and VC, and expected contributions from new products in the fluorochemical business [2] - The projected net profits for 2025, 2026, and 2027 are 1.1 billion, 2.4 billion, and 2.98 billion yuan respectively, reflecting year-on-year growth of 17%, 118%, and 25% [2]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to achieve a total revenue of 9.638 billion yuan in 2025, representing a year-on-year increase of 22.82% [7] - The estimated net profit attributable to shareholders for 2025 is 1.098 billion yuan, reflecting a year-on-year growth of 16.54% [7] - The report highlights that the price increase of hexafluoropropylene has contributed significantly to profit recovery, with a projected profit contribution of around 1 billion yuan from the electrolyte segment in Q4 2025 [7] - The company anticipates a robust growth in the fluorochemical sector, with an estimated profit contribution of approximately 10 billion yuan in 2026 [7] Financial Projections - Total revenue projections for the company are as follows: - 2023: 7.484 billion yuan - 2024: 7.847 billion yuan - 2025: 9.638 billion yuan - 2026: 13.719 billion yuan - 2027: 16.947 billion yuan [1][8] - Net profit attributable to shareholders is projected to be: - 2023: 1.011 billion yuan - 2024: 942 million yuan - 2025: 1.098 billion yuan - 2026: 2.397 billion yuan - 2027: 2.985 billion yuan [1][8] - The earnings per share (EPS) estimates are: - 2023: 1.34 yuan - 2024: 1.25 yuan - 2025: 1.46 yuan - 2026: 3.19 yuan - 2027: 3.97 yuan [1][8] Market Data - The closing price of the company's stock is 50.88 yuan, with a market capitalization of approximately 38.251 billion yuan [5] - The price-to-earnings (P/E) ratio is projected to be 34.84 for 2025 and 15.96 for 2026 [1][8] - The company has a net asset value per share of 13.40 yuan [6]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to achieve a total revenue of 9.638 billion yuan in 2025, representing a year-on-year increase of 22.82% [7] - The estimated net profit attributable to shareholders for 2025 is 1.098 billion yuan, reflecting a year-on-year growth of 16.54% [7] - The report highlights that the price increase of hexafluoropropylene has contributed significantly to profit recovery, with a projected profit contribution of around 1 billion yuan from the electrolyte segment in Q4 2025 [7] - The company anticipates a robust growth in the fluorochemical sector, with an estimated profit contribution of approximately 10 billion yuan in 2026 [7] Financial Projections - Total revenue projections for the company are as follows: - 2023: 7.484 billion yuan - 2024: 7.847 billion yuan - 2025: 9.638 billion yuan - 2026: 13.719 billion yuan - 2027: 16.947 billion yuan [1][8] - Net profit attributable to shareholders is projected to be: - 2023: 1.011 billion yuan - 2024: 942 million yuan - 2025: 1.098 billion yuan - 2026: 2.397 billion yuan - 2027: 2.985 billion yuan [1][8] - The report estimates the earnings per share (EPS) to be: - 2023: 1.34 yuan - 2024: 1.25 yuan - 2025: 1.46 yuan - 2026: 3.19 yuan - 2027: 3.97 yuan [1][8] Market Data - The closing price of the company's stock is 50.88 yuan, with a market capitalization of approximately 38.251 billion yuan [5] - The price-to-earnings (P/E) ratio is projected to be 34.84 for 2025 and 15.96 for 2026 [1][8] - The company has a net asset value per share of 13.40 yuan [6]

Core Viewpoint - Shenzhen Xinzhoubang Technology Co., Ltd. has officially initiated its listing process in Hong Kong, with CITIC Securities and CICC serving as joint sponsors [1][8]. Company Overview - Founded in 2002, Xinzhoubang has a history dating back to 1996 and has been deeply involved in the electronic chemicals industry for nearly three decades. The company aims to create a better future through electronic chemicals and functional materials, becoming a global leader in this sector [1][9]. Business Segments - **Battery Chemicals**: Xinzhoubang is one of the early entrants in lithium-ion battery electrolyte production in China, achieving a vertical integration value chain. From 2020 to 2024, the company ranked among the top three globally in battery electrolyte sales, with a projected global market share of 13.5% in 2024 [3][11]. - **Organic Fluorinated Chemicals**: The company has established a complete fluorochemical industry chain, with its HFPO and downstream products leading in domestic production and sales. The HFE cleaning agent holds the highest market share among local companies, serving high-end sectors such as AI, digital infrastructure, and clean energy [3][11]. - **Electronic Information Chemicals**: The capacitor chemicals segment has maintained the highest global market share for five consecutive years, reaching 27.9% in 2024. The semiconductor chemicals segment has also achieved stable supply to major domestic IC manufacturers [3][11]. Production and Supply Chain - Xinzhoubang operates 14 production bases globally, with 13 in China and one in Europe, and is constructing additional facilities in Southeast Asia. The company is the only large-scale electrolyte manufacturer globally with self-sufficiency in solutes, solvents, and additives [4][12][13]. Market Growth and Financial Performance - The company’s core businesses benefit from strong demand in high-growth markets. The projected market sizes for 2024 are: battery chemicals at over 33.1 billion RMB, organic fluorinated chemicals at 158.5 billion RMB, capacitor chemicals at 2.7 billion RMB, and wet electronic chemicals at 75.3 billion RMB, with expected compound annual growth rates of 23.5%, 13.6%, 10.6%, and 9.8% respectively from 2025 to 2029 [4][13]. - Financially, Xinzhoubang reported revenues of 7.472 billion RMB in 2023, 7.836 billion RMB in 2024, and 6.607 billion RMB for the first nine months of 2025, with net profits of 1.014 billion RMB, 950.586 million RMB, and 771.514 million RMB respectively [5][14][15]. Future Plans - The company plans to use the funds raised from the IPO to enhance its localized and integrated strategic layout, support R&D capabilities across its three business segments, upgrade digital infrastructure, and supplement working capital [6][14]. - By listing on the Hong Kong Stock Exchange, Xinzhoubang aims to enhance its international brand influence, broaden overseas financing channels, and optimize corporate governance structures, thereby supporting global business expansion and technological innovation [7][16].